Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$2.7B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.39B |
| 3 |
AbbVie
ABBV
|
+$1.95B |
| 4 |
Wells Fargo
WFC
|
+$1.03B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trip.com Group
TCOM
|
+$546M |
| 2 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
+$274M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$273M |
| 4 |
Home Depot
HD
|
+$257M |
| 5 |
Progressive
PGR
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.23% |
| 2 | Healthcare | 10.87% |
| 3 | Financials | 9.03% |
| 4 | Technology | 8.57% |
| 5 | Consumer Discretionary | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
DMK
6101
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $12K | ﹤0.01% |
39
+25
| +179% | +$7.55K |
2014 Q2
4 quarters
|
|
|
NYH
6102
DELISTED
Eaton Vance New York Municipal Bond Fund II
NYH
| $12K | ﹤0.01% |
1,000
| – | – |
2013 Q4
6 quarters
|
|
6103
DELISTED
Starz - Series B
STRZB
| $12K | ﹤0.01% |
265
-2
| -0.7% | -$81 |
2014 Q1
5 quarters
|
|
|
EWAS
6104
DELISTED
ISHARES MSCI AUSTRALIA SMALL CAP INDEX FUND
EWAS
| $12K | ﹤0.01% |
735
+535
| +268% | +$9.47K |
2014 Q4
2 quarters
|
|
|
GNVC
6105
DELISTED
GenVec, Inc.
GNVC
| $12K | ﹤0.01% |
593
-1,563
| -72% | -$38.1K |
2013 Q4
6 quarters
|
|
6106
Avino Silver & Gold Mines
ASM
$829M
| $11K | ﹤0.01% |
+10,300
| New | +$12.7K |
2015 Q2
0 quarters
|
|
6107
ZW Data Action Technologies
CNET
$5.21M
| $11K | ﹤0.01% |
171
+1
| +0.6% | +$77 |
2013 Q2
8 quarters
|
|
6108
Landmark Bancorp
LARK
$192M
| $11K | ﹤0.01% |
826
-453
| -35% | -$6.63K |
2013 Q4
6 quarters
|
|
6109
Ocugen
OCGN
$285M
| $11K | ﹤0.01% |
29
-4
| -12% | -$1.93K |
2014 Q4
2 quarters
|
|
6110
DELISTED
S&W Seed Co
SANW
| $11K | ﹤0.01% |
129
-8
| -6% | -$717 |
2013 Q4
6 quarters
|
|
6111
DELISTED
Streamline Health Solutions
STRM
| $11K | ﹤0.01% |
267
+100
| +60% | +$3.78K |
2013 Q4
6 quarters
|
|
6112
Direxion Daily Technology Bear 3x ETF
TECS
$74.4M
| – | – |
0
| – | – |
2013 Q4
6 quarters
|
|
|
FGH
6113
DELISTED
FG Group Holdings Inc.
FGH
| $11K | ﹤0.01% |
2,249
| – | – |
2013 Q2
8 quarters
|
|
|
PTNR
6114
DELISTED
Partner Communications
PTNR
| $11K | ﹤0.01% |
4,376
-4,108
| -48% | -$10.1K |
2013 Q2
8 quarters
|
|
|
BRG
6115
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $11K | ﹤0.01% |
840
-33,463
| -98% | -$450K |
2014 Q4
2 quarters
|
|
|
FCB
6116
DELISTED
FCB Financial Holdings, Inc.
FCB
| $11K | ﹤0.01% |
374
-1,393
| -79% | -$39.8K |
2014 Q3
3 quarters
|
|
6117
DELISTED
Bank Of America Corporation Ws B
BAC.WS.B
| $11K | ﹤0.01% |
21,700
-9,000
| -29% | -$4.76K |
2013 Q2
8 quarters
|
|
6118
DELISTED
Hudbay Minerals Inc.
HBM.WS
| $11K | ﹤0.01% |
13,115
-622
| -5% | -$752 |
2014 Q4
2 quarters
|
|
|
EVAR
6119
DELISTED
Lombard Medical, Inc.
EVAR
| $11K | ﹤0.01% |
2,516
+1
| +0% | +$5 |
2014 Q2
4 quarters
|
|
|
TEAR
6120
DELISTED
TearLab Corporation
TEAR
| $11K | ﹤0.01% |
548
-300
| -35% | -$7.04K |
2013 Q4
6 quarters
|
|
|
EPRS
6121
DELISTED
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
| $11K | ﹤0.01% |
1,816
-2,512
| -58% | -$17.1K |
2014 Q3
3 quarters
|
|
|
MY
6122
DELISTED
CHINA MING YANG WIND PWR GRP LTD ADS RSPTG 1 ORD SHS (CHINA)
MY
| $11K | ﹤0.01% |
3,648
+1,225
| +51% | +$3.92K |
2013 Q4
6 quarters
|
|
|
PLM
6123
DELISTED
PolyMet Mining Corp.
PLM
| $11K | ﹤0.01% |
955
+150
| +19% | +$1.77K |
2013 Q4
6 quarters
|
|
6124
Cellectar Biosciences
CLRB
$11.2M
| – | – |
0
| – | – |
2014 Q3
3 quarters
|
|
6125
Eagle Point Credit Company
ECC
$379M
| $10K | ﹤0.01% |
+500
| New | +$10.3K |
2015 Q2
0 quarters
|
|
Similar funds
Morgan Stanley's Q2 2015 Portfolio in Review
As of Q2 2015, Morgan Stanley held 7,065 positions worth $289B, up 6.3% from $272B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley deployed $19B of net new capital in Q2 2015, opening 213 new positions and adding to 3,439 existing holdings. Its largest new stake was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Trip.com Group, an estimated $546M trimmed.
- Morgan Stanley's largest Q2 2015 buy was EQGP Holdings, LP: 2,862,984 shares worth $97.3M.
- Morgan Stanley added most to Express Scripts Holding Company in Q2 2015, an estimated $2.7B increase.
- Morgan Stanley's biggest Q2 2015 reduction was Trip.com Group, cutting an estimated $546M.
- Morgan Stanley fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $162M.
- Morgan Stanley's ten largest holdings make up 12% of its $289B portfolio in Q2 2015.
- Morgan Stanley opened 213 new positions and closed 120 in Q2 2015.
- Morgan Stanley's portfolio value rose 6.3% quarter-over-quarter to $289B.
Based on Morgan Stanley's 13F filing for Q2 2015, filed 12 Aug 2015.